Aarti Asnani, MD discusses anthracyline-induced cardiomyopathy, including risk mitigation strategies, underlying pathogenesis, genetic variants associated with increased risk of this adverse event, and gaps in our understanding. Moderated by Sarah Waliany, MD, MS.

JACC: CardioOncology Pulse - Clinical Risk Mitigation, Pathophysiology, and Genetics of Anthracycline-Associated Cardiomyopathy

In this podcast series, editors-in-chief from the JACC family of specialty journals provide highlights and summarize key findings for select issues. Published by the American College of Cardiology, the JACC Journals publish peer-reviewed articles on all aspects of cardiovascular disease, including original clinical studies, translational investigations with clear clinical relevance, state-of-the art papers, and review articles. They are top ranked for impact factor and their manuscripts are among the most covered by media outlets, most talked about on social media, and most read online.

Medicine

Science & Medicine

Science

Health & Fitness

Life Sciences

JACC: Clinical Electrophysiology -  Long Term Freedom from Ventricular Arrhythmias in ARVC with Endocardial Only Ablation: Predictors of Success

JACC: Clinical Electrophysiology -  Peri-Procedural Intravascular Hemolysis during Atrial Fibrillation Ablation: A Comparison of Pulsed Field with Radiofrequency Ablation

JACC: Clinical Electrophysiology -  A Comparison of the Association of Septal Scar Burden on Responses to LBBAP-CRT and BVP-CRT

JACC: Asia - Pulmonary Hypertension With Interstitial Pneumonia: Initial Treatment Effectiveness and Severity in a Japan Registry

JACC: Asia - Machine Learning-Based Discrimination of Cardiovascular Outcomes in Patients With Hypertrophic Cardiomyopathy

JACC Specialty Journals

JACC: CardioOncology Pulse - Clinical Risk Mitigation, Pathophysiology, and Genetics of Anthracycline-Associated Cardiomyopathy

Download our free app to listen on your phone